Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway

Abstract Bladder cancer (BLCA) is one of the ten most common cancers worldwide. However, the deregulation of PROS1 and its specific function in BLCA is not well understood. By combining proteomic and transcriptomic datasets, we discovered PROS1 expression was significantly reduced in BLCA tissues an...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin-peng Fan, Ji-rong Wang, Si-yu Chen, Xiao-ran Li, Jin-long Cao, Hua-bin Wang, Li-yun Ding, Tuan-jie Che, Li Yang
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-89217-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862458240991232
author Xin-peng Fan
Ji-rong Wang
Si-yu Chen
Xiao-ran Li
Jin-long Cao
Hua-bin Wang
Li-yun Ding
Tuan-jie Che
Li Yang
author_facet Xin-peng Fan
Ji-rong Wang
Si-yu Chen
Xiao-ran Li
Jin-long Cao
Hua-bin Wang
Li-yun Ding
Tuan-jie Che
Li Yang
author_sort Xin-peng Fan
collection DOAJ
description Abstract Bladder cancer (BLCA) is one of the ten most common cancers worldwide. However, the deregulation of PROS1 and its specific function in BLCA is not well understood. By combining proteomic and transcriptomic datasets, we discovered PROS1 expression was significantly reduced in BLCA tissues and revealed the clinical relevance of PROS1 with BLCA. Analysis of multiple BLCA datasets consistently showed the group with reduced PROS1 expression was linked to cancer-promoting pathways, more aggressive characteristics, and a greater chance of responding positively to immunotherapy. Next, various functional experiments were performed and the results revealed PROS1 overexpression inhibited the proliferation, cell cycle progression, migration, invasion, and angiogenesis of BLCA. In recovery trials, the AKT activator SC79 offered additional proof that PROS1 may influence BLCA cells via the AKT/GSK3β/β-catenin pathway. In conclusion, as an angiogenesis-related gene, PROS1 may play an inhibitory role in the biological functions of bladder cancer.
format Article
id doaj-art-1727d8eddfb5433c9bfb2604cba3f89e
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-1727d8eddfb5433c9bfb2604cba3f89e2025-02-09T12:32:03ZengNature PortfolioScientific Reports2045-23222025-02-0115112310.1038/s41598-025-89217-4Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathwayXin-peng Fan0Ji-rong Wang1Si-yu Chen2Xiao-ran Li3Jin-long Cao4Hua-bin Wang5Li-yun Ding6Tuan-jie Che7Li Yang8Department of Urology, The Second Hospital of Lanzhou UniversityDepartment of Urology, The Second Hospital of Lanzhou UniversityDepartment of Urology, The Second Hospital of Lanzhou UniversityDepartment of Urology, The Second Hospital of Lanzhou UniversityDepartment of Urology, The Second Hospital of Lanzhou UniversityDepartment of Urology, The Second Hospital of Lanzhou UniversitySchool of Physical Science and Technology, Lanzhou UniversityBaiyuan Company for Gene TechnologyDepartment of Urology, The Second Hospital of Lanzhou UniversityAbstract Bladder cancer (BLCA) is one of the ten most common cancers worldwide. However, the deregulation of PROS1 and its specific function in BLCA is not well understood. By combining proteomic and transcriptomic datasets, we discovered PROS1 expression was significantly reduced in BLCA tissues and revealed the clinical relevance of PROS1 with BLCA. Analysis of multiple BLCA datasets consistently showed the group with reduced PROS1 expression was linked to cancer-promoting pathways, more aggressive characteristics, and a greater chance of responding positively to immunotherapy. Next, various functional experiments were performed and the results revealed PROS1 overexpression inhibited the proliferation, cell cycle progression, migration, invasion, and angiogenesis of BLCA. In recovery trials, the AKT activator SC79 offered additional proof that PROS1 may influence BLCA cells via the AKT/GSK3β/β-catenin pathway. In conclusion, as an angiogenesis-related gene, PROS1 may play an inhibitory role in the biological functions of bladder cancer.https://doi.org/10.1038/s41598-025-89217-4Bladder cancerPROS1AngiogenesisBioinformaticsVitro and vivo functional experiment
spellingShingle Xin-peng Fan
Ji-rong Wang
Si-yu Chen
Xiao-ran Li
Jin-long Cao
Hua-bin Wang
Li-yun Ding
Tuan-jie Che
Li Yang
Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
Scientific Reports
Bladder cancer
PROS1
Angiogenesis
Bioinformatics
Vitro and vivo functional experiment
title Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
title_full Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
title_fullStr Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
title_full_unstemmed Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
title_short Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
title_sort mechanistic insights into pros1 inhibition of bladder cancer progression and angiogenesis via the akt gsk3β β catenin pathway
topic Bladder cancer
PROS1
Angiogenesis
Bioinformatics
Vitro and vivo functional experiment
url https://doi.org/10.1038/s41598-025-89217-4
work_keys_str_mv AT xinpengfan mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway
AT jirongwang mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway
AT siyuchen mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway
AT xiaoranli mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway
AT jinlongcao mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway
AT huabinwang mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway
AT liyunding mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway
AT tuanjieche mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway
AT liyang mechanisticinsightsintopros1inhibitionofbladdercancerprogressionandangiogenesisviatheaktgsk3bbcateninpathway